Clinical pharmacology in gastroenterology: Development of new forms of treatment of inflammatory bowel disease

Scandinavian Journal of Gastroenterology, Supplement

Volumn 31, Issue 216, 1996, Pages 175-180

  Brynskov, J ^a   Rasmussen, S Nørby ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

Crohn's disease; cyclosporin; Inflammatory bowel disease; Mesalazine; Ulcerative colitis

Indexed keywords

CYCLOSPORIN A; MESALAZINE; AMINOSALICYLIC ACID DERIVATIVE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

CLINICAL TRIAL; CROHN DISEASE; DRUG DEVELOPMENT; ENTERITIS; HUMAN; PRIORITY JOURNAL; REVIEW; SUSTAINED RELEASE PREPARATION; ULCERATIVE COLITIS; DELAYED RELEASE FORMULATION; DENMARK; HISTORY;

AMINOSALICYLIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS; COLITIS, ULCERATIVE; CROHN DISEASE; CYCLOSPORINE; DELAYED-ACTION PREPARATIONS; DENMARK; HISTORY, 20TH CENTURY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MESALAMINE;

EID: 0029715655     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Hodgson HFJ. One disease or two? In: Allan RN, Keighley MRB, Alexander-Williams J, Hawkins CF, editors. Inflammatory bowel diseases. 2nd ed. London: Churchill Livingstone, 1990:121-6.
2. Brynskov J, Nielsen OH, Ahnefeldt-Rønne I, Bendtzen K. Review: Cytokines in inflammatory bowel disease. Scand J Gastroenterol 1992;27:897-906.
3. Brynskov J. Review: cyclosporin for inflammatory bowel disease, mechanisms and possible actions. Scand J Gastroenterol 1993;28:849-57.
4. Brynskov J. Cyclosporin in Crohn's disease. Therapeutic and pathogenetic implications [Thesis]. Copenhagen: Lægeforeningens forlag, 1994.
5. Brynskov J, Nielsen OH, Ahnefeldt-Ronne I, Bendtzen K. Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review. Dig Dis 1994;12:290-304.
6. Present DH, Korelitz BI, Wisch N. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980;302:981-7.
7. Khan AKA, Piris J, Truelove SC. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 1977;ii: 892-5.
8. Rasmussen SN, Bondesen S, Hvidberg EF, et al. 5-aminosalicylic acid in a slow release preparation: bioavailability, plasma level and excretion in humans. Gastroenterology 1982;83:1062-70.
9. Rasmussen SN, Binder V, Maier K, et al. Treatment of Crohn's disease with peroral 5-aminosalicylic acid. Gastroenterology 1983;85:1350-3.
10. Nielsen OH, Bondesen S. Kinetics of 5-aminosalicylic acid after jejunal instillation in man. Br J Clin Pharmacol 1983;16: 738-40.
11. Bondesen S, Tage-Jensen U, Jacobsen O, et al. 5-aminosalicylic .acid in patients with ileo-rectal anastomosis. A comparison of the fate of sulphasalazine and Pentasa. Eur J Clin Pharmacol 1986;31:23-6.
12. Fallingborg J, Christensen LA, Ingeman-Nielsen M, et al. pH profile and regional transit times of the gut measured by a radio-telemetry device. Aliment Pharmacol Therap 1989;3:605-13.
13. Fallingborg J, Christensen LA, Ingeman-Nielsen M, et al. Measurement of gastrointestinal pH, and regional transit times in normal children. J Pediatr Gastroenterol. Nütz 1990;11: 211-4.